A global leading company focused on improving how scientists utilize knowledge & data to predict the properties/outcomes of pharmaceutical & biotech agents.
Los Angeles, CA
Joined September 2011
- Tweets3.9K
- Following592
- Followers919
- Likes862
Simulations Plus retweeted
If you’ll be at this year’s QSP symposium, don’t miss out on connecting with Principal Scientist Christina Battista. She’s an expert in modeling immune involvement in DILI, IPF, ILD, and NAFLD and would love to share her knowledge and learn from you, too. simulations-plus.com/events/…
Simulations Plus retweeted
Thank you @SimulationsPlus for the ‘Excellence in Academia’ award! Humbled and honored to receive this award! Congratulations to CJ Musante and Ana Ruiz ! #WomenInScience #MIDD  – at Chapel Hill, NC
Simulations Plus retweeted
Meet CSO, Viera Lukacova, who will present "Absorption Predictions: Current Capabilities and Knowing the Gaps", in booth #30 at ISSX/MDO 2022 - mailchi.mp/ad3e61214801/issx…
Simulations Plus retweeted
Last month Hesperos hosted a webinar with @SimulationsPlus to discuss how data from our Human-on-a-Chip when paired with PK/PD models can predict clinical outcomes.
Watch the full webinar here: buff.ly/3wa56wW
#hesperos #simulationsplus #webinar #humanonachip
Simulations Plus retweeted
Register now for our next Simulx webinar! In an hour, we will take you from the modeling of phase II studies in Monolix to the estimation of a phase III study power in Simulx and finally optimizing sample size and study duration. us02web.zoom.us/webinar/regi… #webinar #monolix #simulx
Simulations Plus retweeted
Interested in using #mathematics to solve problems encountered in the #pharmaceutical industry? Register to attend this online seminar for an introduction to #systemsModelling + career options. Sponsored by @PfizerCA @SimulationsPlus @MetrumRG @GSK ow.ly/sH7L50At5V8
Simulations Plus retweeted
For ALS patients taking riluzole, about 50% experience liver enzyme elevations. DILIsym computational modeling of mechanisms suggests that BHV-0223 may be a safer therapeutic alternative for the liver. #OpenAccess @BHowell_DILIsym @BiohavenPharma bit.ly/ToxSci175-2Longo
Simulations Plus retweeted
The first video of our webinar series is online. Learn what are the current c-QTc modeling objectives and how to perform the FDA recommended c-QTc analysis in MonolixSuite #cQTc_analysis #Monolix #qtprolongation #webinarseries #ICH_E14
youtu.be/ifWC7Xd79QE
Simulations Plus retweeted
Tune in on 3/27 for a free webinar on 21st Century Research – Moving Beyond Animals for Toxicity Testing and Coronavirus Research. Experts from @the_iivs @SimulationsPlus & @PCRM will focus on in vitro & in silico testing & research methods.
Register at: zoom.us/webinar/register/WN_…
Simulations Plus retweeted
Dr. Joyce Macwan from @SimulationsPlus shares valuable PBBM and Virtual Bioequivalence Assessment insights to Support Formulation Development at the #18thInternationalSymposium of #CRS !
Simulations Plus retweeted
CRS-IC 2020 Speaker Title:
“Physiologically Based Biopharmaceutics Modeling and Virtual Bioequivalence Assessment to Support Formulation Development.”
Be there at the symposium to hear on this from Grace Fraczkiewicz, Simulations Plus, Inc who has huge experience in the field.
Simulations Plus retweeted
.#LA based @SimulationsPlus to collaborate with @Bayer on Predictive Software. #MachineLearning #drugdiscovery #healthcare @SFVBJ
.
.
.
Full article - bit.ly/2LpJ04E
Simulations Plus retweeted
Bayer And Simulations Plus Collaborate to Advance ADMET Predictor for Improving Data Integrity in Drug Discovery @Bayer @SimulationsPlus
pharmashots.com/24431/bayer-…
Simulations Plus retweeted
@daga_pankaj from @SimulationsPlus will speak on Friday (Sep 13) at 11 am PDT about importance of data curation in the age of #AI.
More details here: openforcefield.org/news/webi…
Zoom link: ucihealth.zoom.us/j/97247497…
Simulations Plus retweeted
Is it time to get #scrappy? Of course it is! Thanks to Arlene Padron of @SimulationsPlus for stopping by our booth at #cmworld2019 !
Simulations Plus retweeted
.@PISCLtd co-authored paper, "Pathway-based predictive approaches for non-animal assessment of acute inhalation toxicity," is an Honorable Mention winner for Best Paper of 2018 by @SOToxicology Biological Modeling Specialty Section. Access the paper here: bit.ly/2MzGVSE
Simulations Plus retweeted
The cofounder of Words+ Inc. and @SimulationsPlus, Walt Woltosz, will be the keynote speaker at the fall commencement ceremonies this Saturday, Dec. 15.
1,750 degrees will be conferred during two ceremonies in Auburn Arena.
🎓#AuburnGrad
Details: ocm.auburn.edu/newsroom/news…
Simulations Plus retweeted
Secure collaboration and file organization can be a pain point when distributed researchers need to work together. At Cognigen Corporation, a Simulations Plus Company, I am working with a talented team along with colleagues at Medicines for Malaria Ventur…lnkd.in/eTEe482
Simulations Plus retweeted
Today is #WorldMSDay, we traveled across Europe, enabling our Biogen teams to experience one aspect of living with MS by walking in specially designed shoes. Watch our 6 city European journey and show your support by sharing the videos! #bringinguscloser